Expert consensus post-marketing evaluation scheme to detect immunotoxicity of Chinese medicine in clinical populations (draft version for comments) / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 2933-2936, 2013.
Article
in Chinese
| WPRIM
| ID: wpr-238579
ABSTRACT
Through consensus, establish a post-marketing scheme and the technical processes to evaluate Chinese medicine's immunotoxicity on a population, as well as its beneficial influences on the immune system. Provide regulations on the collection, storage and transportation of serum samples. This article applies to the post-marketing scientific evaluation of the immunotoxicity of parenterally administered, and for other ways of taking Chinese medicine.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Product Surveillance, Postmarketing
/
Reference Standards
/
Drugs, Chinese Herbal
/
Immunologic Techniques
/
Drug Monitoring
/
Th2 Cells
/
Th1 Cells
/
Consensus
/
Drug Hypersensitivity
/
Allergy and Immunology
Type of study:
Practice guideline
Limits:
Humans
Language:
Chinese
Journal:
China Journal of Chinese Materia Medica
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS